UBS Group’s ETRACS 2x Leveraged US Growth Factor TR ETN IWFL Stock Holding History

UBS Group’s Portfolio IWFL Stock Details IWFL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$4.53K	–	10740
2026 Q1	$4.53K	Buy	+100	New	+$5.21K	﹤0.01%	8927
2024 Q2	–	Sell	-33	Closed	-$1.19K	–	9790
2024 Q1	$1.19K	Buy	+33	New	+$1.1K	﹤0.01%	8197
2023 Q1	–	Sell	-919	Closed	-$14.9K	–	9966
2022 Q4	$14.9K	Hold	919	–	–	﹤0.01%	8038
2022 Q3	$15K	Buy	919 +765	+497%	+$15.1K	﹤0.01%	7803
2022 Q2	$3K	Buy	+154	New	+$3.37K	﹤0.01%	9329

Other funds holding IWFL

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group's IWFL Position: Q2 2026 in Review

UBS Group sold out of ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) in Q2 2026, closing a stake of 100 shares — an estimated $4.53K sold.

UBS Group first reported a position in IWFL in Q2 2022 and held it in 5 quarters. The position peaked at $15K in Q3 2022. 1 fund tracked by Wall St. Rank holds IWFL as of Q2 2026.

UBS Group reported no remaining ETRACS 2x Leveraged US Growth Factor TR ETN position as of Q2 2026 after selling out during the quarter.
UBS Group sold 100 ETRACS 2x Leveraged US Growth Factor TR ETN shares in Q2 2026, an estimated $4.53K.
UBS Group first reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN in Q2 2022 and held it in 5 quarters.
UBS Group's ETRACS 2x Leveraged US Growth Factor TR ETN position peaked at $15K in Q3 2022.
1 fund tracked by Wall St. Rank held ETRACS 2x Leveraged US Growth Factor TR ETN as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.